Nichol KL. The health and economic benefits of influenza vaccination for healthy and at-risk persons aged 65 to 74 years. Pharmacoeconomics 1999; 16 Suppl. 1: 63–71
Bootman JL, Townsend RJ, McGhan WF. Principles of pharmacoeconomics. 2nd ed. Cincinnati: Harvey-Whitney Books Company, 1996
Kozma CM, Reeder CE, Schulz RM. Economic, clinical and humanistic outcomes: a planning model for pharmacoeconomic research. Clin Ther 1993; 15 (6): 1121–32
Rennie D. The present state of medical journals. Lancet 1998; 175 (352): SII18–22
Milne RJ. Pharmacoeconomic models in disease management. Dis Manage Health Outcomes 1998; 4 (3): 119–34
Lundberg GD. A Christmas fairy tale. BMJ 1996; 131: 1612
Drummond MF, O’Brien B, Stoddart GL, et al. Methods for the evaluation of health care programmes. 2nd ed. Oxford: Oxford University Press, 1997
Basskin LE. Practical pharmacoeconomics. How to design, perform and analyze outcomes research. Cleveland, Ohio: Advanstar Communications Inc., 1998
Drummond MF, Jefferson TO, for the Working Party on Guidelines for Authors and Peer Reviewers of Economic Submissions to the British Medical Journal. Guidelines for authors and peer-reviewers of economic submissions to the British Medical Journal. BMJ 1996; 313: 275–383
Jefferson TO, Smith R, Yee Y, et al. Evaluating the BMJ guidelines for economic submissions. Prospective audit of economic submissions to BMJ and The Lancet. JAMA 1998; 280 (3): 275–7